Rylaze® (asparaginase erwinia chrysanthemi (recombinant)-rywn)
for Lymphoma

Rylaze (asparaginase erwinia chrysanthemi recombinant-rywn) is an antineoplastic medicine used alongside other cancer drugs to treat acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in adults and children aged 1 month and older. It targets and destroys cancer cells in patients who previously experienced allergic reactions to E. coli-derived asparaginase.

Heart